BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

66 related articles for article (PubMed ID: 2983003)

  • 1. Lack of quantitative correlation between the neutralization of poliovirus and the antibody-mediated pI shift of the virions.
    Brioen P; Thomas AA; Boeyé A
    J Gen Virol; 1985 Mar; 66 ( Pt 3)():609-13. PubMed ID: 2983003
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hit-and-run neutralization of poliovirus.
    Brioen P; Rombaut B; Boeyé A
    J Gen Virol; 1985 Nov; 66 ( Pt 11)():2495-9. PubMed ID: 2997379
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Relationship between poliovirus neutralization and aggregation.
    Thomas AA; Vrijsen R; Boeyé A
    J Virol; 1986 Aug; 59(2):479-85. PubMed ID: 3016307
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bivalent attachment of antibody onto poliovirus leads to conformational alteration and neutralization.
    Emini EA; Ostapchuk P; Wimmer E
    J Virol; 1983 Nov; 48(2):547-50. PubMed ID: 6194315
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Functional basis of poliovirus neutralization determined with monospecific neutralizing antibodies.
    Emini EA; Kao SY; Lewis AJ; Crainic R; Wimmer E
    J Virol; 1983 May; 46(2):466-74. PubMed ID: 6188863
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neutralization of poliovirus by antibody-mediated polymerization.
    Brioen P; Dekegel D; Boeyé A
    Virology; 1983 Jun; 127(2):463-8. PubMed ID: 6306919
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evidence for several unrelated neutralization epitopes of poliovirus, type 1, strain Mahoney, provided by neutralization tests and quantitative enzyme-linked immunosorbent assay (ELISA).
    Uhlig H; Rutter G; Dernick R
    J Gen Virol; 1983 Dec; 64 ( Pt 12)():2809-12. PubMed ID: 6198443
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A monoclonal antibody that neutralizes poliovirus by cross-linking virions.
    Thomas AA; Brioen P; Boeyé A
    J Virol; 1985 Apr; 54(1):7-13. PubMed ID: 2983121
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mapping of type 1 poliovirus neutralization epitopes.
    Blondel B; Crainic R; Dufraisse G; Candréa A; Horaud F
    Dev Biol Stand; 1985; 60():337-42. PubMed ID: 2412917
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Capsid destabilization is required for antibody-mediated disruption of poliovirus.
    Delaet I; Boeyé A
    J Gen Virol; 1994 Mar; 75 ( Pt 3)():581-7. PubMed ID: 8126454
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Poliovirus neutralization and the percentage law. Brief report.
    Brioen P; Boeyé A
    Arch Virol; 1985; 83(1-2):105-11. PubMed ID: 2982345
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mechanisms of neutralization of animal viruses.
    Dimmock NJ
    J Gen Virol; 1984 Jun; 65 ( Pt 6)():1015-22. PubMed ID: 6202836
    [No Abstract]   [Full Text] [Related]  

  • 13. Antigenic analysis of poliovirus type 3 using monoclonal antibodies.
    Ferguson M; Minor PD; Magrath DI; Schild GC
    Dev Biol Stand; 1984; 57():151-5. PubMed ID: 6098495
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Monoclonal antibodies reveal in blocking reactions the antigenicity and antibody response of poliovirus.
    Uhlig H; Rutter G; Dernick R
    Dev Biol Stand; 1984; 57():187-91. PubMed ID: 6084610
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Application of monoclonal antibodies for the identification of the antigenic site for poliovirus neutralization.
    Minor PD; Schild GC; Evans D; Ferguson M; Almond J
    Dev Biol Stand; 1984; 57():171-5. PubMed ID: 6084608
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Monoclonal antibodies reactive with different sites of N and H antigenic particles of poliovirus.
    Taniguchi K; Urasawa S; Urasawa T
    J Gen Virol; 1983 Dec; 64 ( Pt 12)():2803-8. PubMed ID: 6198442
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The use of a monoclonal antibody and of DNA recombinant technology for the localization of a poliovirus neutralization epitope in viral capsid polypeptide VP1.
    Bruneau P; van der Werf S; Wychowski C; Siffert O; Girard M
    Dev Biol Stand; 1984; 57():177-85. PubMed ID: 6084609
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Principal and subsidiary antigenic sites of VP1 involved in the neutralization of poliovirus type 3.
    Minor PD; Evans DM; Ferguson M; Schild GC; Westrop G; Almond JW
    J Gen Virol; 1985 May; 66 ( Pt 5)():1159-65. PubMed ID: 2582084
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antigenic sites of poliovirus type 3 eliciting IgA monoclonal antibodies in orally immunized mice.
    Buttinelli G; Ruggeri FM; Marturano J; Novello F; Donati V; Fiore L
    Virology; 2001 Mar; 281(2):265-71. PubMed ID: 11277698
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antigenic modification of attenuated Sabin type 1 poliovirus by in vitro passages at supraoptimal temperatures.
    Crainic R; Blondel B; Candréa A; Dufraisse G; Horaud F
    Dev Biol Stand; 1985; 60():343-7. PubMed ID: 2995173
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.